台湾的生物技术创新在BIO2024上引起国际关注-动脉网

Taiwan’s Biotech Innovations Draw International Attention at BIO 2024

GeneOnline 等信源发布 2024-06-26 17:25



可切换为仅中文







by Bernice Lottering

作者：Bernice Lottering

Share To

共享给

Pei-Li Chen, Deputy Director-General of the Industrial Development Bureau, Ministry of Economic Affairs in her opening speech at the Taiwan Pavilion in US BIO in San Diego this year.The 2024 BIO International Convention, the world’s largest biotechnology event, took place in San Diego, USA, from June 3 to 6.

经济部工业发展局副局长陈佩丽（音译）今年在圣地亚哥美国生物技术馆（US BIO）的台湾馆致开幕词。2024年生物技术国际会议是世界上最大的生物技术活动，于6月3日至6日在美国圣地亚哥举行。

This year’s convention drew biomedical investors and research experts worldwide. Over 1,500 exhibitors showcased their innovations to more than 19,500 attendees from 70 countries. The Taiwan Pavilion garnered significant attention, holding over 400 meetings in four days and highlighting Taiwan’s rising biotech industry.Leading Taiwanese Pharmaceutical Companies’ Capabilities ShowcasedThe 2024 BIO International Convention’s theme was “Time for Science to Shine.” The Taiwan delegation, organized by the Ministry of Economic Affairs (MOEA) Biotechnology and Pharmaceutical Industries Promotion Office, in collaboration with the Ministry of Health and Welfare, Ministry of Agriculture, National Science and Technology Council, National Development Council, Taipei City Government, and the National Biotechnology Research Park.

今年的大会吸引了全世界的生物医学投资者和研究专家。1500多家参展商向来自70个国家的19500多名与会者展示了他们的创新成果。台湾馆引起了极大关注，在四天内举行了400多次会议，突出了台湾正在崛起的生物技术产业。领先的台湾制药公司的能力展示了2024年生物技术国际大会的主题是“科学发光的时刻”。台湾代表团由经济部生物技术和制药工业促进办公室组织，与卫生福利部、农业部、国家科技委员会、国家发展委员会、台北市政府和国家生物技术研究园合作。

The delegation included over 80 companies and institutions, with around 230 participants. 臺灣代表團由經濟部生醫推動小組協同衛福部、農業部、國科會、國發會、北市府、國家生技研究園區等部會法.The delegation focused on new drug development, biotechnology, CDMO (Contract Development and Manufacturing Organization), medical devices, precision medicine, regenerative medicine, agricultural biotechnology, and smart health.

The delegation included over 80 companies and institutions，with around 230 participants.台湾代表团由经济部生医推动小组协同卫福部、农业部、国科会、国发会、北市府、国家生技研究园区等部会法.The delegation focused on new drug development，biotechnology，CDMO（Contract Development and Manufacturing Organization），medical devices, precision medicine, regenerative medicine, agricultural biotechnology, and smart health.

International buyers showed strong interest in cancer treatment and CDMO, indicating significant investment potential.The Taiwan Pavilion featured a CDMO wall showcasing 10 leading Taiwanese pharmaceutical companies’ capabilities. This display highlighted Taiwan’s strengths in intellectual pr.

国际买家对癌症治疗和CDMO表现出强烈的兴趣，表明投资潜力巨大。台湾馆以CDMO墙为特色，展示了10家领先的台湾制药公司的能力。这一展示突显了台湾在知识公关方面的优势。

BIO 2024 Showcases the Emergence of Taiwan’s Biotech CDMO MarketTaiwan Biotech Forum Kicks Off in San Diego Ahead of BIO 2024

BIO 2024展示了台湾生物技术CDMO市场的出现台湾生物技术论坛在BIO 2024之前在圣地亚哥开幕

Author

作者

Bernice Lottering

伯尼斯彩票